The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

Client Partner Profiles

High Expectations, Inspired By Patients and Fueled By Innovation

September 14, 2021
With a pipeline of more than 40 medicines, Ionis Pharmaceuticals is using its groundbreaking antisense therapies to bring better health and healing to millions of people. As clinical development and commercialization efforts continue to accelerate, Ionis works with The Chase Group to find leaders and executives who share a passion for helping patients, strive for excellence, and dare to dream big. Continue Reading →

Delivering Better Cancer Outcomes With the Best Teams

September 3, 2021
Checkmate Pharmaceuticals, a clinical stage immuno-oncology company, is focused on pioneering new medicines for combating melanoma, non-melanoma skin cancers, and head and neck cancer. Dr. James Wooldridge, Chief Medical Officer, has partnered with The Chase Group on executive search projects because of the thoroughness, productivity, and expert evaluations he receives from Chase as he builds out his clinical development and regulatory affairs teams at this fast-moving startup. Continue Reading →

The Most Difficult Executive Searches – Completed Faster and Easier

June 8, 2021
Dr. Tahamtan Ahmadi, Executive Vice President and Chief Medical Officer at Genmab A/S is responsible for the overall research organization and strategic drug development functions. Specialists with deep drug development experience in oncology are critical to Genmab’s development efforts – and are among the most difficult to identify, entice, and attract. Dr. Ahmadi works with The Chase Group on his key executive searches because of the firm’s ability to match the vision and needs of Genmab with the motivations, strengths, and goals of the best candidates. Continue Reading →

Building the Next Generation of RNA Medicines – With Exceptional Talent

May 22, 2021
Arcturus Therapeutics, an RNA medicines company engaged in the development of therapeutics for rare diseases and vaccines – including one in clinical trials for COVID-19 – is growing quickly and adding key executives in clinical development and drug safety. To find this elite group of clinicians, the company relies on The Chase Group and its network of carefully curated candidates, expert screening skills, and comprehensive project management that leaves nothing to chance. Continue Reading →

Developing Transformative Antibodies That Improve the Lives of Cancer Patients

December 12, 2019
Dr. Kate Sasser, Corporate Vice President, Head of Translational Research, and her team at Genmab A/S understand how antibodies work and use this rare expertise to develop antibody therapeutics that treat solid tumors and hematological cancers. The company has 18 products in clinical development and approximately 20 pre-clinical programs, and Dr. Sasser’s team is growing, so she counts on The Chase Group to recruit the highly-specialized professionals she needs to keep pipeline development healthy and moving forward. Continue Reading →

A Passion For Bringing New Drugs To Market – With the Best People

July 20, 2018
The pipeline of rare disease drugs in development at Ionis Pharmaceuticals has grown significantly in the last five years. And, with a robust pipeline combined with a commercialization strategy, including complex partnerships involving complicated deal structures, financial leadership roles are key to managing the process and bringing life-changing therapies to market. When Ionis needs to fill critical leadership roles, The Chase Group delivers outstanding people who are committed to the mission and the culture. Continue Reading →

Exceptional Performance Requires Exceptional Talent

September 11, 2017
Genmab A/S is a biotechnology company specializing in the creation and development of antibody therapeutics for the treatment of cancer. When highly specialized executives must be recruited, Genmab relies on The Chase Group for their professionalism, tenacity, skill, and more than 25 years of life sciences recruitment success. Continue Reading →

Creating a Healthy Pipeline of Scientific Discovery, Drug Development – and People

July 31, 2017
Ionis Pharmaceuticals, a leader in drug discovery and development for rare diseases, has over 450 employees worldwide. When executives at Ionis need to fill crucial roles in various areas, they count on The Chase Group to deliver the best process, performance and people. Continue Reading →
© Copyright 1993-2021 The Chase Group; All Rights Reserved.